WashU Expert: EpiPen controversy highlights need for price controls
Recent scandals involving high-priced generic drugs should prompt us to consider price controls for pharmaceutical companies, says an expert on the health care industry at the School of Law at Washington University.
Weidenbaum Center forum series to open with discussion of excise taxes in health care
The Weidenbaum Center on the Economy, Government, and Public Policy will kick off its fall forum series with a half-day symposium on “Taxing Temptation: Excise Taxes and Health” from 9 a.m.-noon Sept. 23 in the Bryan Cave Moot Courtroom in Anheuser-Busch Hall. The series, which is free and open to the public, also includes forums on education finance (Nov. 4) and monetary policy (Nov. 30).